Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists

Overview of attention for article published in JACC, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 4 news outlets

twitter: 80 X users

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 39 publications that cite this research output.

39

The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.

Paradoxical real-life underuse of GLP-1 receptor agonists in type 2 diabetes patients with atherosclerotic cardiovascular disease Underuse of GLP-1RAs in patients with ASCVD

Article in Diabetes Epidemiology and Management (April 2024)

Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)

Article in Clinical Drug Investigation (March 2024)

Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Article in Cardiovascular Diabetology (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.